2018_3q_omron_e
36/50 - HCB Targets Innovation in Hypertension Treatment
【テロップ】
※各テロップ文字をクリックすると該当の場所がピンポイントで閲覧できます。
00:27:20.7
OMRON is able to capture a broad array of vital signs using a variety of wearable devices, not just conventional blood pressure readings but readings of blood pressure post-activity or during sleep, or upon waking. We are also able to factor in new types of vital signs such as ECG. By analyzing such new data for a given individual, we believe it should be possible to tailor a treatment program, including identifying the correct medication, so that it best suits the individual’s needs. We are currently developing this type of service. We believe the analytical process is an ongoing and iterative process, so that even after lowering blood pressure using medication, we could subsequently modify a treatment program, where the next step might be to aim for a change in behavior that incorporates more exercise or a reduction of salt in the diet. We aim to develop this type of service as well.
【ノート】
